Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B - Wikidata - wikimedia - TriplyDB

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

http://www.wikidata.org/entity/Q28379350

about

Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression.Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID)Secretion of interleukin-8 by human-derived cell lines infected with Mycobacterium bovis Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668].Cancer-associated fibroblasts in hepatocellular carcinoma Suppression of RelA/p65 nuclear translocation independent of IkappaB-alpha degradation by cyclooxygenase-2 inhibitor in gastric cancer Nuclear factor-kappa B activation in human testicular apoptosis Effect of 4-trifluoromethyl derivatives of salicylate on nuclear factor kappaB-dependent transcription in human astrocytoma cells Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression Acquired resistance of human T cells to sulfasalazine: stability of the resistant phenotype and sensitivity to non-related DMARDs Development of sulfasalazine resistance in human T cells induces expression of the multidrug resistance transporter ABCG2 (BCRP) and augmented production of TNFalpha Role of IKK/NF-κB signaling in extinction of conditioned place aversion memory in rats High-Throughput Assay Development for Cystine-Glutamate Antiporter (xc-) Highlights Faster Cystine Uptake than Glutamate Release in Glioma Cells Addition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 Mice Effect of sulfasalazine on renal ischemia/reperfusion injury in rats [Conventional basis therapy of rheumatoid arthritis. Effects within and outside cells].Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering A role for the canonical nuclear factor-κB pathway in coupling neurotrophin-induced differential survival of developing spiral ganglion neurons.Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes.Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis.Synergistic activation of NF-kappab and inducible isoform of nitric oxide synthase induction by interferon-gamma and tumor necrosis factor-alpha in INS-1 cells.An NF-kappaB and slug regulatory loop active in early vertebrate mesoderm.Early termination of ISRCTN45828668, a phase 1/2 prospective, randomized study of sulfasalazine for the treatment of progressing malignant gliomas in adults Signal transduction and transcription factors in rheumatic disease.Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.The levels of RAC3 expression are up regulated by TNF in the inflammatory response.Nuclear factor-kappa B (NFkappaB) component p50 in blood mononuclear cells regulates endothelial tissue factor expression in sickle transgenic mice: implications for the coagulopathy of sickle cell disease.Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells.Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models.Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo.5-Aminosalicylic Acid Inhibits Acute Clostridium difficile Toxin A-Induced Colitis in Rats.Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-alpha signaling.Protein degradation by ubiquitin-proteasome system in formation and labilization of contextual conditioning memory.Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism Series introduction: the transcription factor NF-kappaB and human disease

P2860

Q24536188-BA5707EF-D05E-4476-A819-9527D0429C71 Q24681630-6F5C59A3-C23E-4E01-9D33-779E7B8E4156 Q24681818-8653D78E-16D2-444E-B3B4-076285043FFD Q24683212-387152D4-9052-4D17-B759-D4B13437DFD8 Q24812982-BAB19026-CC24-44BE-B982-12698913C29C Q25257862-4556CF9D-B179-4CCF-BF8C-1C2B921040C1 Q26738536-14C147E6-7224-40A5-B7C8-BCED7E79B63A Q28195124-6D32980B-58BB-47F9-82F1-49770D099BB8 Q28344806-A170476E-FC2B-48A0-A17B-4A6E4575B6FE Q28346425-CB9C7BCD-27B7-4C21-B740-80CB2E4B8F45 Q28347747-B4EEC9E6-A7D0-453A-A6F3-2168423788DF Q28394186-E9E7055F-F38A-4B5D-91AC-72B8CE0A3C21 Q28394197-6084CCCC-05D5-486D-BEAF-79A14C3CA1ED Q28480639-B95F84D3-7111-45FB-B9E0-2A86722493E5 Q28547125-627E7B83-B754-4908-9CA4-AFE0B90C879D Q28551369-80193D7C-D10A-4A8F-BD10-C4F4B1FF3439 Q28564809-7A947DD6-0474-44DF-B84C-EB3B1ED0413F Q30318026-9A7475D3-629F-4656-9131-292403B9941F Q30349885-4DE355BA-4B96-4BE6-B4BC-93D806FFC41E Q30415505-B5111DB9-2CB7-4D2D-83F5-CB14078893D0 Q30445818-E4BB1B1E-51A9-4E94-8854-560C5A8AE07B Q30638019-D6783566-52CC-48D9-8B26-073E01D9CA9E Q30856787-3113F1A0-E21F-45AD-BCBA-5463D00D09FA Q31386037-95710B13-C794-433D-93F9-A526B363F57E Q33268281-434C99BF-833B-49F9-86F8-096C2192D8E6 Q33511367-A18D5CD6-34C8-41F1-8518-21DF45E81C87 Q33598827-00EC228C-911C-4067-9DEE-832D4B3A84F1 Q33680480-916FF892-4770-4D1A-95F9-AE769914AE3B Q33729031-C357F613-2AE6-47D8-B64B-18E083EA826B Q33761124-3888B648-8509-4F7A-B4BA-D38B3BA35B14 Q33768874-3F66DB44-C58B-4108-BF98-31B4CBB4CA41 Q33795121-EC60F067-3BEB-45DC-A695-2415AFC09CAD Q33797156-BCF054C0-004D-46BB-B8D6-36982D88415E Q33868970-A1C427CC-C820-4E4A-8B16-DCBEE7AF192D Q33872837-F34ED3DA-0B3F-492F-9E0D-B557144E17D5 Q33876268-C5E585CD-620A-4454-8D88-ED812E17DC13 Q33893095-037062F5-02EE-42F4-8D1E-7AD249F0350B Q34067424-84093301-E6C6-4915-978A-14BE1297FD0B Q34079481-6D3F5FBE-FA47-4184-B758-E97E40F31FE6 Q34116362-2833E079-2631-45EE-B7F2-F40E2F6EA89F

P2860

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

http://www.wikidata.org/entity/Q28379350

description

1998 nî lūn-bûn

@nan

1998 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի մարտին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

@ast

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

@en

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

@nl

type

label

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

@ast

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

@en

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

@nl

prefLabel

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

@ast

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

@en

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

@nl

P1433

Q28379350-E32ABAAC-1362-4514-86C4-5A5457B92B19

P1476

Q28379350-9512932B-D5C0-4BE2-9D4A-8C160FD24B22

P2093

Q28379350-01AEBCE8-D978-4D16-8784-8DEF3665EA4F

Q28379350-08F9B742-7D44-43CB-993E-B362B1AE8D0C

Q28379350-7636E38E-C690-40AF-9361-3267CA2C0256

Q28379350-DBEBCED5-581B-4FD5-9B05-185EAE900256

P2860

Q28379350-09D8FAB2-EB3C-43C7-9EB7-3F50DB1B5A7F

Q28379350-2721714F-4C58-40DC-BA85-45BFF3BC434A

Q28379350-286E5337-82D9-461A-9B21-B77CFA9A6D29

Q28379350-31F2A7E0-F034-4240-B5FD-6F770A485899

Q28379350-323FA967-9939-4A3B-81B8-59FEBECD26F3

Q28379350-373B0BBC-C7D0-4A91-A256-03A5C22D378C

Q28379350-3AC010E7-0BE3-4936-BBF4-D8C3C8048AC1

Q28379350-3AD69A4A-56B4-445B-8093-64B9F80DE1D8

Q28379350-4D154FCA-3269-4B32-AC58-51477B1EB9EC

Q28379350-534E1D56-2111-4525-9A49-C92DC04057FE

P304

Q28379350-CF20E2BB-57BE-4541-A339-3BCFC69AAF84

P31

Q28379350-85AEC308-4DD5-4E91-BFE0-FB0B2DEE9827

P3181

Q28379350-9C9650D1-99B7-4678-87C8-47EEB3CDC0E4

P356

Q28379350-9A7BFD4A-A922-4595-A88F-FA4B6EA68643

P407

Q28379350-A99E8C33-7399-423B-944D-179DE59E2058

P433

Q28379350-EE05AE0B-F066-4683-BCE0-8A21630FA683

P478

Q28379350-4A08A318-884D-4C5A-B3A8-7CEF33A7B2F2

P577

Q28379350-24C475CB-00DB-4594-B82F-5D2E1AA96441

P5875

Q28379350-E259E56E-2A44-4934-83F8-F4ABB44FF7C2

P698

Q28379350-89B9E339-F1E4-4167-A50D-DABB7F5AD333

P932

Q28379350-9DB6B7A7-E1B3-402A-B987-203B6E8B1062

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

@en

P2093

C Wahl

http://www.w3.org/2001/XMLSchema#string

G Adler

http://www.w3.org/2001/XMLSchema#string

R M Schmid

http://www.w3.org/2001/XMLSchema#string

S Liptay

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65

Dimerization of NF-KB2 with RelA(p65) regulates DNA binding, transcriptional activation, and inhibition by an I kappa B-alpha (MAD-3)

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation

Inhibition of NF-kappa B by sodium salicylate and aspirin

Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

NF-kappa B: ten years after

Structure, regulation and function of NF-kappa B

P304

1163-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1386989

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI992

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P577

1998-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13744659

http://www.w3.org/2001/XMLSchema#string

P698

9486988

http://www.w3.org/2001/XMLSchema#string

P932

508669

http://www.w3.org/2001/XMLSchema#string